Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. [electronic resource]
Producer: 19990413Description: 2095-102 p. digitalISSN:- 0022-1767
- Aniline Compounds -- antagonists & inhibitors
- Biological Transport -- drug effects
- Cell Nucleus -- drug effects
- Ceramides -- antagonists & inhibitors
- Chloramphenicol O-Acetyltransferase -- antagonists & inhibitors
- Crotonates
- DNA-Binding Proteins -- antagonists & inhibitors
- Dithiothreitol -- pharmacology
- Enzyme Activation -- drug effects
- Gene Expression Regulation -- drug effects
- Genes, MDR -- drug effects
- Genes, Reporter -- drug effects
- Host Cell Factor C1
- Humans
- Hydrogen Peroxide -- antagonists & inhibitors
- Hydroxybutyrates -- antagonists & inhibitors
- I-kappa B Proteins
- Immunosuppressive Agents -- antagonists & inhibitors
- Isoxazoles -- antagonists & inhibitors
- Leflunomide
- Lipopolysaccharides -- antagonists & inhibitors
- Lymphocyte Specific Protein Tyrosine Kinase p56(lck) -- antagonists & inhibitors
- Mitogen-Activated Protein Kinase Kinases
- NF-KappaB Inhibitor alpha
- NF-kappa B -- antagonists & inhibitors
- NF-kappa B p50 Subunit
- Nitriles
- Octamer Transcription Factor-1
- Okadaic Acid -- antagonists & inhibitors
- Protein Binding -- drug effects
- Protein Kinase Inhibitors
- Protein Kinases -- metabolism
- Tetradecanoylphorbol Acetate -- antagonists & inhibitors
- Toluidines
- Transcription Factor AP-1 -- metabolism
- Transcription Factor RelA
- Transcription Factors -- metabolism
- Tumor Cells, Cultured
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.